EIF2B1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.077900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.006010E-01
Normal-vs-Stage2
5.926000E-02
Normal-vs-Stage3
1.791850E-01
Normal-vs-Stage4
3.486200E-01
Stage1-vs-Stage2
6.926600E-01
Stage1-vs-Stage3
4.487400E-01
Stage1-vs-Stage4
6.129400E-01
Stage2-vs-Stage3
5.175400E-01
Stage2-vs-Stage4
4.234800E-01
Stage3-vs-Stage4
3.975600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.136300E-02
Normal-vs-AfricanAmerican
3.730300E-02
Normal-vs-Asian
1.968190E-02
Caucasian-vs-AfricanAmerican
2.254800E-01
Caucasian-vs-Asian
3.542500E-02
AfricanAmerican-vs-Asian
7.371000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.101200E-01
Normal-vs-Female
4.149900E-02
Male-vs-Female
6.104200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.552010E-01
Normal-vs-Age(41-60Yrs)
1.105830E-01
Normal-vs-Age(61-80Yrs)
6.074200E-02
Normal-vs-Age(81-100Yrs)
1.187560E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.056000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.715600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.984200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.027500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.710800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.040000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.050400E-02
Normal-vs-Daily Drinker
1.628970E-01
Normal-vs-Weekly Drinker
2.342000E-01
Normal-vs-Occasional Drinker
1.626360E-01
Normal-vs-Social Drinker
4.397600E-02
Non Drinker-vs-Daily Drinker
1.131440E-01
Non Drinker-vs-Weekly Drinker
2.948400E-01
Non Drinker-vs-Occasional Drinker
2.781800E-02
Non Drinker-vs-Social Drinker
1.068430E-01
Daily Drinker-vs-Weekly Drinker
8.422600E-01
Daily Drinker-vs-Occasional Drinker
6.011800E-01
Daily Drinker-vs-Social Drinker
9.809600E-01
Weekly Drinker-vs-Occasional Drinker
5.334400E-01
Weekly Drinker-vs-Social Drinker
8.546000E-01
Occasional Drinker-vs-Social Drinker
5.266000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.729800E-01
Normal-vs-Grade 2
9.516200E-01
Normal-vs-Grade 3
9.088200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.278600E-01
Grade 1-vs-Grade 3
3.269600E-01
Grade 1-vs-Grade 4
9.729800E-01
Grade 2-vs-Grade 3
1.968770E-01
Grade 2-vs-Grade 4
9.516200E-01
Grade 3-vs-Grade 4
9.088200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.436200E-02
Normal-vs-NonDiabetic
7.612400E-02
Diabetic-vs-NonDiabetic
4.488800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.557500E-02
Normal-vs-NoPancreatitis
6.260300E-02
Pancreatitis-vs-NoPancreatitis
6.522000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.012590E-01
Normal-vs-N1
7.053500E-02
N0-vs-N1
4.695400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.639760E-01
Normal-vs-TP53-NonMutant
2.027600E-01
TP53-Mutant-vs-TP53-NonMutant
5.710200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
